Humankind Investments LLC Trims Stake in Cigna Group $CI

Humankind Investments LLC cut its stake in shares of Cigna Group (NYSE:CI) by 54.6% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,576 shares of the health services provider’s stock after selling 3,097 shares during the period. Humankind Investments LLC’s holdings in Cigna Group were worth $852,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of the stock. ICONIQ Capital LLC raised its stake in shares of Cigna Group by 8.0% in the second quarter. ICONIQ Capital LLC now owns 1,642 shares of the health services provider’s stock worth $543,000 after buying an additional 121 shares during the period. Fullerton Fund Management Co Ltd. increased its holdings in Cigna Group by 88.4% in the 2nd quarter. Fullerton Fund Management Co Ltd. now owns 1,345 shares of the health services provider’s stock worth $445,000 after acquiring an additional 631 shares in the last quarter. Gallagher Fiduciary Advisors LLC raised its stake in Cigna Group by 9.5% during the 2nd quarter. Gallagher Fiduciary Advisors LLC now owns 1,297 shares of the health services provider’s stock worth $429,000 after acquiring an additional 112 shares during the period. Engineers Gate Manager LP lifted its holdings in Cigna Group by 966.9% during the second quarter. Engineers Gate Manager LP now owns 11,725 shares of the health services provider’s stock valued at $3,876,000 after purchasing an additional 10,626 shares in the last quarter. Finally, Curi Capital LLC bought a new position in shares of Cigna Group in the second quarter worth approximately $341,000. Institutional investors own 86.99% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on CI. Wells Fargo & Company decreased their price objective on shares of Cigna Group from $354.00 to $300.00 and set an “equal weight” rating on the stock in a research report on Wednesday, November 5th. The Goldman Sachs Group lowered their price objective on Cigna Group from $370.00 to $330.00 and set a “buy” rating on the stock in a research report on Tuesday, November 4th. Leerink Partners dropped their price objective on Cigna Group from $300.00 to $270.00 in a research note on Friday, October 31st. Deutsche Bank Aktiengesellschaft decreased their target price on Cigna Group from $415.00 to $301.00 and set a “buy” rating on the stock in a research note on Monday, November 3rd. Finally, Jefferies Financial Group restated a “buy” rating and issued a $310.00 price target on shares of Cigna Group in a research note on Monday, November 3rd. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $331.77.

Cigna Group Stock Performance

NYSE CI opened at $274.70 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.76 and a quick ratio of 0.76. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00. The business has a 50 day simple moving average of $280.44 and a two-hundred day simple moving average of $294.17. The stock has a market capitalization of $73.38 billion, a PE ratio of 12.12, a P/E/G ratio of 0.99 and a beta of 0.26.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, October 30th. The health services provider reported $7.83 EPS for the quarter, beating analysts’ consensus estimates of $7.64 by $0.19. Cigna Group had a return on equity of 18.80% and a net margin of 2.29%.The firm had revenue of $69.57 billion during the quarter, compared to the consensus estimate of $66.40 billion. During the same period in the prior year, the company earned $7.51 EPS. The company’s quarterly revenue was up 9.5% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, research analysts predict that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 18th. Shareholders of record on Thursday, December 4th will be paid a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend is Thursday, December 4th. Cigna Group’s dividend payout ratio (DPR) is presently 26.64%.

Insider Transactions at Cigna Group

In other Cigna Group news, CEO David Cordani bought 4,134 shares of the firm’s stock in a transaction dated Monday, November 3rd. The shares were purchased at an average cost of $241.88 per share, for a total transaction of $999,931.92. Following the transaction, the chief executive officer owned 157,935 shares of the company’s stock, valued at $38,201,317.80. This represents a 2.69% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Brian C. Evanko sold 5,368 shares of the stock in a transaction dated Friday, October 3rd. The shares were sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the completion of the transaction, the insider directly owned 51,182 shares of the company’s stock, valued at approximately $15,354,600. The trade was a 9.49% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.70% of the company’s stock.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.